Difference between revisions of "CT Angiography Biomarker Ctte"

From QIBA Wiki
Jump to navigation Jump to search
Line 34: Line 34:
 
==Profile Development==
 
==Profile Development==
  
−
*[[Media:QIBA CTA Profile as of 2023-Feb-16.pdf| CT Atherosclerosis 2023-02-16]]
+
*[[Media:QIBA CTA Profile as of 2023-Feb-16.pdf|QIBA Atherosclerosis Biomarkers Profile Draft]]
−
*[[Media:QIBA CTA Profile as of 2020-Mar-10.pdf|CTA Atherosclerosis 2020-03-10]]
+
*[[Media:QIBA CTA Profile as of 2020-Mar-10.pdf|QIBA Atherosclerosis Biomarkers Profile Draft]]
−
*[[Media:QIBA CTA Field Test Checklist.xlsx|Checklists - CTA Atherosclerosis 2020-05-28]]
+
*[[Media:QIBA CTA Field Test Checklist.xlsx|QIBA Atherosclerosis Checklists]]
 
*[[Media:Atherosclerosis Biomarkers Profile 2019-11-27-full.PDF| QIBA Atherosclerosis Biomarkers Profile Draft]]
 
*[[Media:Atherosclerosis Biomarkers Profile 2019-11-27-full.PDF| QIBA Atherosclerosis Biomarkers Profile Draft]]
 
*[[Media:Atherosclerosis Biomarkers Profile 2019-11-27.PDF| QIBA Atherosclerosis Biomarkers Profile Draft (reduced page count)]]
 
*[[Media:Atherosclerosis Biomarkers Profile 2019-11-27.PDF| QIBA Atherosclerosis Biomarkers Profile Draft (reduced page count)]]

Revision as of 17:30, 29 March 2023

Co-chairs: Andrew Buckler, MS, PhD; Luca Saba, MD; Uwe Joseph Schoepf, MD, FAHA, FSCBT-MR, FNASCI, FSCCT

RSNA Staff Support: Julie Lisiecki


Meetings

Recent Call Summaries:


CT Angiography Call Summaries Archive

Project Snapshot - CT Angiography

The group intends to pursue writing quantitative profiles for both Coronary computed tomography angiography (CCTA) and CT angiography (CTA).

Excerpt from the biomarker committee submission form:

The QIBA Atherosclerosis Biomarkers Committee (ABC) is organized to document quantitative profiles for both Computed Tomography Angiography (CTA) and Coronary CTA (CCTA). The membership is composed of participants from multiple centers of excellence within North America and Europe utilizing different CTA vendors, acquisitions and scanner types, and analysis software vendors. Representatives from different manufacturers are included in the committee, who are interested in working closely with the committee in optimizing imaging biomarkers for scientific trials and clinical routine use. The Biomarker Committee develops technical performance standards to serve as atherosclerosis compositional biomarkers, engaging stakeholders from different societies, in addition to the RSNA, for example ASNR, SCCT, ACR, etc.

Profile Development

Atherosclerosis Biomarkers Profile Draft Archive

Groundwork Projects

Reference Materials

Conformance Materials

Retrieved from "https://qibawiki.rsna.org/index.php?title=CT_Angiography_Biomarker_Ctte&oldid=18911"